Glucagon-zoo li peptide-1 (GLP-1) yog cov tshuaj hormones tseem ceeb hauv lub cev tswj cov ntshav qab zib thiab qab los noj mov. Nws ua lub luag haujlwm tseem ceeb hauv kev ua haujlwm metabolic, tshwj xeeb tshaj yog nyob rau hauv cov ntsiab lus ntawm kev tswj cov mob xws li hom 2 mob ntshav qab zib thiab rog rog. GLP-1 ua haujlwm raws li cov tshuaj hormones incretin, cuam tshuam rau kev tso tawm insulin, inhibiting glucagon tso tawm, thiab txhawb kev satiety. Nws cov peev xwm kho tau ua rau GLP-1 receptor agonists, ib chav kawm ntawm cov tshuaj siv los kho cov kab mob metabolic. Cov tshuaj no tau hloov pauv thaj chaw kho mob ntshav qab zib thiab rog rog, muab cov kev daws teeb meem zoo rau kev txhim kho cov ntshav qabzib thiab tswj qhov hnyav. Hauv tsab xov xwm no, peb yuav tshawb xyuas cov txheej txheem ntawm GLP-1, nws cov kev siv tshuaj kho mob, thiab kev nyab xeeb thiab kev ua tau zoo ntawm GLP-based tshuaj hauv cov tshuaj niaj hnub.
Mechanism ntawm GLP-1
GLP-1 yog peptide hormone uas feem ntau tsim hauv cov hnyuv, tshwj xeeb hauv L-hlwb. Thaum noj zaub mov, GLP-1 tau tso tawm rau hauv cov hlab ntsha, qhov uas nws ua rau muaj ntau yam cuam tshuam rau kev tswj cov piam thaj hauv homeostasis. Ib lub luag haujlwm tseem ceeb tshaj plaws ntawm GLP-1 yog nyob rau hauv kev tswj hwm ntawm insulin secretion. Thaum cov piam thaj nkag mus rau hauv cov hlab ntsha tom qab noj mov, GLP-1 nkoos pancreas kom tso tawm insulin. Cov tshuaj insulin no pab cov cell nqus cov piam thaj, txo cov ntshav qab zib. Cov nyhuv no yog qhov tseem ceeb tshwj xeeb tshaj yog rau cov tib neeg uas muaj ntshav qab zib hom 2, qhov twg lub cev muaj peev xwm tsim lossis teb rau cov tshuaj insulin raug cuam tshuam.
Ntxiv nrog rau stimulating insulin secretion, GLP-1 inhibits glucagon tso tawm ntawm pancreas. Glucagon yog ib yam tshuaj uas qhia lub siab kom tso cov piam thaj tso rau hauv cov hlab ntsha. Los ntawm inhibiting glucagon, GLP-1 tiv thaiv cov piam thaj ntau dhau, pab ntxiv rau kev tswj ntshav qab zib. Qhov kev ua thib ob - txhawb nqa insulin thiab inhibiting glucagon - pab tswj cov ntshav qabzib sib luag, tshwj xeeb yog tom qab noj mov.
Lwm qhov haujlwm tseem ceeb ntawm GLP-1 yog nws cov txiaj ntsig ntawm lub plab khoob thiab satiety. GLP-1 ua rau cov txheej txheem ntawm lub plab khoob, uas pab cov tib neeg hnov qab ntev dua tom qab noj mov. Qhov no txo qis plab khoob, ua ke nrog kev nce siab hauv kev xav ntawm fullness (satiety), pab txhawb kev qab los noj mov. Cov teebmeem no ua rau GLP-1 muaj txiaj ntsig tshwj xeeb rau cov neeg rog rog, vim nws pab tswj lawv cov calorie kom tsawg.
Lawv Ua Haujlwm Li Cas?
GLP-raws li tshuaj, tseem hu ua GLP-1 receptor agonists, yog ib chav kawm ntawm cov tshuaj uas ua raws li cov txiaj ntsig ntawm cov tshuaj hormone glucagon-zoo li peptide-1 (GLP-1). GLP-1 yog tsim nyob rau hauv cov hnyuv tom qab noj mov thiab ua lub luag haujlwm tseem ceeb hauv kev tswj cov ntshav qabzib, qab los noj mov, thiab kev tso tawm ntawm insulin. Cov tshuaj no khi rau GLP-1 receptors ntawm ntau lub hlwb thoob plaws hauv lub cev, ua rau cov lus teb zoo ib yam li lub ntuj tsim ntawm GLP-1. Lawv lub hom phiaj tseem ceeb yog txhim kho ntshav qabzib tswj thiab txo lub cev hnyav rau cov tib neeg uas muaj ntshav qab zib hom 2 thiab rog rog.
Thaum GLP-1 receptor agonists raug tswj hwm, lawv pab txhim kho insulin secretion hauv cov lus teb rau cov zaub mov, inhibit qhov tso tawm ntawm glucagon (ib yam tshuaj uas ua rau cov ntshav qabzib), thiab ua rau lub plab zom mov qeeb, ua rau muaj kev xav ntau ntxiv. Cov kev sib xyaw ua ke no ua rau GLP-1 cov tshuaj muaj txiaj ntsig zoo hauv ob qho tib si tswj ntshav qab zib thiab txhawb kev poob phaus.
Qee qhov feem ntau tshaj tawm GLP-1 receptor agonists suav nrog semaglutide, liraglutide, thiab exenatide. Txhua yam ntawm cov tshuaj no txawv nyob rau hauv cov nqe lus ntawm pharmacokinetics (yuav ua li cas lub cev absorbs, faib, metabolizes, thiab excretes cov tshuaj), lub sij hawm noj, thiab kev siv tshwj xeeb, muab yooj yim rau cov kws kho mob hauv kev kho cov neeg mob sib txawv xav tau kev pab.
Semaglutid (Ozempic, Wegovy) : Semaglutid yog ib qho zoo tshaj plaws GLP-1 receptor agonists. Nws tau pom tias txo qis HbA1c qib (ib qho cim rau kev tswj ntshav qabzib mus ntev) thiab txhawb kev poob phaus. Feem ntau siv ib zaug ib lub lim tiam, nws muab cov neeg mob lub sijhawm noj tshuaj yooj yim, ua rau nws yog qhov kev xaiv nrov rau cov neeg uas muaj kev ua neej tsis khoom lossis cov neeg uas pom cov kev txhaj tshuaj txhua hnub nyuaj.
Liraglutide (Victoza, Saxenda) : Liraglutide yog lwm qhov siv dav hauv GLP-1 agonist, muaj nyob rau hauv ob hom tshuaj-Victoza rau ntshav qab zib thiab Saxenda rau kev poob phaus. Cov tshuaj no yog siv txhua hnub thiab tau pom tias muaj txiaj ntsig zoo hauv kev txhim kho glycemic tswj thiab txhawb kev tswj qhov hnyav hauv cov tib neeg uas muaj ntshav qab zib hom 2 thiab rog rog.
Exenatide (Byteta, Bydureon) : Exenatide yog ib qho ntawm thawj GLP-1 receptor agonists pom zoo siv rau kev kho mob ntshav qab zib hom 2. Nws muaj nyob rau hauv ob daim ntawv: Byetta, uas yog muab ob zaug ib hnub twg, thiab Bydureon, uas yog ib zaug ib lub lim tiam. Ob qho tib si formulations pab tswj cov ntshav qabzib thiab muab cov txiaj ntsig poob phaus.
Cov tshuaj no ua tib zoo ua raws li GLP-1's natural biological functions thiab muab ntau yam txiaj ntsig rau cov tib neeg uas muaj ntshav qab zib hom 2 thiab rog rog. Los ntawm kev tswj cov ntshav qab zib kom zoo thiab pab txo qhov hnyav, lawv ua lub luag haujlwm tseem ceeb hauv kev txhim kho cov metabolism hauv kev noj qab haus huv thiab tag nrho lub neej zoo rau cov neeg mob.
Kev siv tshuaj kho mob GLP-1
Kev kho mob ntshav qab zib hom 2
GLP-1 receptor agonists tau raug pov thawj tias muaj txiaj ntsig zoo hauv kev tswj ntshav qab zib hom 2. Los ntawm kev txhim kho insulin secretion thiab inhibiting glucagon tso tawm, cov tshuaj no txhim kho cov ntshav qabzib, tshwj xeeb tshaj yog tom qab noj mov. Cov tshuaj GLP-1 feem ntau yog siv los ua ib feem ntawm kev kho mob sib xyaw ua ke rau hom 2 mob ntshav qab zib, tshwj xeeb tshaj yog thaum lwm cov tshuaj (xws li metformin) tsis txaus los tswj cov ntshav qab zib.
Hauv kev sim tshuaj, GLP-1 receptor agonists zoo li semaglutide thiab liraglutide tau pom qhov txo qis hauv qib HbA1c, uas yog qhov tseem ceeb rau kev tiv thaiv kev mob ntshav qab zib mus ntev. Tsis tas li ntawd, cov tshuaj no pab txo qis cov piam thaj hauv cov ntshav, muab kev tswj xyuas cov ntshav qab zib kom zoo ib hnub.
Lub luag haujlwm hauv Kev Tswj Kev Noj Qab Haus Huv thiab Metabolic Disorders
GLP-1 receptor agonists tsis yog tsuas yog muaj txiaj ntsig zoo rau kev tswj ntshav qab zib hom 2 - lawv kuj tau pom tias muaj txiaj ntsig zoo hauv kev kho mob rog. Cov tshuaj xws li semaglutide (Wegovy) tau txais kev pom zoo los ntawm FDA rau kev tswj kev poob phaus vim lawv muaj peev xwm txo qis qab los noj mov thiab txhawb kev rog. Los ntawm kev ua kom muaj kev xav puv thiab txo kev tshaib kev nqhis, GLP-1 cov tshuaj pab cov tib neeg xaiv zaub mov noj qab haus huv thiab txo lawv cov calories tag nrho.
Ntxiv mus, cov tshuaj GLP-1 tau cuam tshuam nrog kev txhim kho cov hlab plawv hauv cov neeg mob rog. Rau cov tib neeg uas muaj cov kab mob metabolic, uas suav nrog cov kab mob xws li ntshav siab, rog dhau ntawm lub duav, thiab cov roj (cholesterol) siab, GLP-1 cov tshuaj muaj kev qhia dav rau kev tswj hwm ntau yam ntawm tus mob no.
Kev nyab xeeb thiab kev phiv ntawm cov tshuaj GLP-1
Thaum cov tshuaj GLP-1 feem ntau suav hais tias muaj kev nyab xeeb thiab siv tau, lawv tuaj yeem ua rau muaj kev phiv rau qee tus neeg. Cov kev mob tshwm sim uas tshwm sim feem ntau yog mob plab hnyuv, nrog rau xeev siab, ntuav, thiab raws plab. Cov kev mob tshwm sim no feem ntau yog ib ntus thiab txo qis thaum lub cev hloov kho rau cov tshuaj.
Muaj qee zaus, qee tus neeg yuav muaj kev phiv loj dua, xws li pancreatitis lossis teeb meem raum. Nws yog ib qho tseem ceeb rau cov neeg mob tham txog lawv cov keeb kwm kho mob nrog lawv cov kws kho mob ua ntej pib siv tshuaj GLP-1 kom ntseeg tau tias nws yog kev kho mob zoo rau lawv.
Lwm qhov kev phiv tshwm sim yog hypoglycemia (cov ntshav qab zib tsawg), tshwj xeeb tshaj yog siv cov tshuaj GLP-1 nrog rau lwm cov tshuaj ntshav qab zib xws li sulfonylurea lossis insulin. Txawm li cas los xij, kev pheej hmoo ntawm hypoglycemia nrog cov tshuaj GLP-1 ib leeg yog qhov qis dua piv rau lwm cov kev kho mob ntshav qab zib.
Xaus
Cov tshuaj GLP-1 tau hloov pauv cov toj roob hauv pes ntawm hom 2 mob ntshav qab zib mellitus thiab kev kho mob rog, muab kev daws teeb meem zoo rau kev tswj cov ntshav qab zib thiab txhawb kev poob phaus. Cov tshuaj no, los ntawm kev ua raws li cov tshuaj hormones GLP-1, tswj cov tshuaj insulin secretion, suppress qab los noj mov, thiab tswj cov piam thaj homeostasis. Nrog rau lawv cov txiaj ntsig pov thawj thiab qhov cuam tshuam tsis zoo, GLP-1 cov tshuaj yog cov cuab yeej tseem ceeb hauv kev tswj cov kab mob metabolic.
Raws li kev tshawb fawb tsis tu ncua nthuav tawm cov tshiab thiab qib siab dua GLP-1 receptor agonists, cov tshuaj no tau npaj los txhim kho lub neej ntawm ntau lab tus neeg muaj kev rog rog, ntshav qab zib hom 2, thiab lwm yam mob. Thaum ua ke nrog kev saib xyuas thiab kho kom raug, cov tshuaj GLP-1 muab cov txiaj ntsig zoo hauv kev tswj hwm kev noj qab haus huv metabolic thiab txhim kho lub neej zoo.
Rau cov neeg nrhiav kev paub ntau ntxiv txog kev kho mob thiab kev daws teeb meem hauv kev noj qab haus huv hauv metabolic, peb pom zoo kom mus ntsib Cocer Peptides Co., Ltd. Txawm hais tias koj tab tom nrhiav kev kho mob los yog nrhiav kev cob qhia, Cocer Peptides Co., Ltd. Hu rau lawv hnub no kom paub ntau ntxiv txog yuav ua li cas lawv tuaj yeem pab txhawb koj txoj kev mus rau kev noj qab haus huv zoo dua.
